— Know what they know.
Not Investment Advice

REPH Institutional Ownership

Recro Pharma, Inc.
1W: +7.2% 1M: +25.1% 3M: +26.7% 1Y: -43.4% 3Y: -78.2% 5Y: -73.8%
$2.09
Last traded 2022-03-21 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $177.4M mcap · 70M float · 0.184% daily turnover

No institutional holdings data available for REPH

Institutional holdings are sourced from SEC 13F filings and may not be available for all securities.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms